Menu
GWAS Study

Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer.

Drew DA, Kim AE, Lin Y et al.

38809988 PubMed ID
GWAS Study Type
72667 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DD
Drew DA
KA
Kim AE
LY
Lin Y
QC
Qu C
MJ
Morrison J
LJ
Lewinger JP
KE
Kawaguchi E
WJ
Wang J
FY
Fu Y
ZN
Zemlianskaia N
DV
Díez-Obrero V
BS
Bien SA
DN
Dimou N
AD
Albanes D
BJ
Baurley JW
WA
Wu AH
BD
Buchanan DD
PJ
Potter JD
PR
Prentice RL
HS
Harlid S
AV
Arndt V
BE
Barry EL
BS
Berndt SI
BE
Bouras E
BH
Brenner H
BA
Budiarto A
BA
Burnett-Hartman A
CP
Campbell PT
CR
Carreras-Torres R
CG
Casey G
CJ
Chang-Claude J
CD
Conti DV
DM
Devall MAM
FJ
Figueiredo JC
GS
Gruber SB
GA
Gsur A
GM
Gunter MJ
HT
Harrison TA
HA
Hidaka A
HM
Hoffmeister M
HJ
Huyghe JR
JM
Jenkins MA
JK
Jordahl KM
KA
Kundaje A
LM
Le Marchand L
LL
Li L
LB
Lynch BM
MN
Murphy N
NR
Nassir R
NP
Newcomb PA
NC
Newton CC
OM
Obón-Santacana M
OS
Ogino S
OJ
Ose J
PR
Pai RK
PJ
Palmer JR
PN
Papadimitriou N
PB
Pardamean B
PA
Pellatt AJ
PA
Peoples AR
PE
Platz EA
RG
Rennert G
RE
Ruiz-Narvaez E
SL
Sakoda LC
SP
Scacheri PC
SS
Schmit SL
SR
Schoen RE
SM
Stern MC
SY
Su YR
TD
Thomas DC
TY
Tian Y
TK
Tsilidis KK
UC
Ulrich CM
UC
Um CY
VD
van Duijnhoven FJB
VG
Van Guelpen B
WE
White E
HL
Hsu L
MV
Moreno V
PU
Peters U
CA
Chan AT
GW
Gauderman WJ
Chapter II

Abstract

Summary of the research findings

Regular, long-term aspirin use may act synergistically with genetic variants, particularly those in mechanistically relevant pathways, to confer a protective effect on colorectal cancer (CRC) risk. We leveraged pooled data from 52 clinical trial, cohort, and case-control studies that included 30,806 CRC cases and 41,861 controls of European ancestry to conduct a genome-wide interaction scan between regular aspirin/nonsteroidal anti-inflammatory drug (NSAID) use and imputed genetic variants. After adjusting for multiple comparisons, we identified statistically significant interactions between regular aspirin/NSAID use and variants in 6q24.1 (top hit rs72833769), which has evidence of influencing expression of TBC1D7 (a subunit of the TSC1-TSC2 complex, a key regulator of MTOR activity), and variants in 5p13.1 (top hit rs350047), which is associated with expression of PTGER4 (codes a cell surface receptor directly involved in the mode of action of aspirin). Genetic variants with functional impact may modulate the chemopreventive effect of regular aspirin use, and our study identifies putative previously unidentified targets for additional mechanistic interrogation.

10,446 European ancestry user cases, 16,838 European ancestry user controls, 20,360 European ancestry non-user cases, 25,023 European ancestry non-user controls

Chapter III

Study Statistics

Key metrics and study information

72667
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Canada, U.S., Finland, U.K., Israel, Australia, Germany, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.